Literature DB >> 2717516

Enhanced intestinal absorption of cyclosporine in rats through the reduction of emulsion droplet size.

B D Tarr1, S H Yalkowsky.   

Abstract

The intestinal absorption of cyclosporine was measured in situ in rats using an olive oil emulsion prepared by either stirring or homogenization. The surface area of the homogenized dosage form was twice that of the stirred dosage form. The apparent permeability of cyclosporine from the homogenized emulsion was about twice that of the emulsion prepared by stirring. The examination of absorption in different intestinal segment lengths suggested the presence of an "absorption window." The absorption of cyclosporine appeared to be concentration independent and, therefore, non-carrier mediated. The dependence of absorption upon the intestinal perfusion rate suggested that the stagnant aqueous layer is the rate-limiting barrier in cyclosporine absorption. These results indicate that the bioavailability of cyclosporine administered in an emulsion can possibly be increased by enhancing its rate of absorption through the reduction of droplet size.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2717516     DOI: 10.1023/a:1015843517762

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  9 in total

1.  Emulsification of fat in the intestine of the rat and its relationship to absorption.

Authors:  A C Frazer; J H Schulman; H C Stewart
Journal:  J Physiol       Date:  1944-12-15       Impact factor: 5.182

2.  Theoretical model studies of intestinal drug absorption. IV. Bile acid transport at premicellar concentrations across diffusion layer-membrane barrier.

Authors:  N F Ho; W I Higuchi
Journal:  J Pharm Sci       Date:  1974-05       Impact factor: 3.534

3.  Biopharmaceutics of drugs administered in lipid-containing dosage forms. I. GI absorption of griseofulvin from an oil-in-water emulsion in the rat.

Authors:  P J Carrigan; T R Bates
Journal:  J Pharm Sci       Date:  1973-09       Impact factor: 3.534

4.  Effect of the application form of cyclosporine on blood levels: comparison of oral solution and capsules.

Authors:  B Nashan; J Bleck; K Wonigeit; P Vogt; U Christians; K F Sewing; T Beveridge; R Pichlmayr
Journal:  Transplant Proc       Date:  1988-04       Impact factor: 1.066

5.  Absorption of cyclosporine A after oral dosing.

Authors:  J Grevel
Journal:  Transplant Proc       Date:  1986-12       Impact factor: 1.066

6.  Absorption of cyclosporine from rabbit small intestine in situ.

Authors:  R J Sawchuk; W M Awni
Journal:  J Pharm Sci       Date:  1986-12       Impact factor: 3.534

7.  Intestinal lymphatic absorption of cyclosporin A following oral administration in an olive oil solution in rats.

Authors:  C T Ueda; M Lemaire; G Gsell; K Nussbaumer
Journal:  Biopharm Drug Dispos       Date:  1983 Apr-Jun       Impact factor: 1.627

Review 8.  Clinical pharmacokinetics of cyclosporin.

Authors:  R J Ptachcinski; R Venkataramanan; G J Burckart
Journal:  Clin Pharmacokinet       Date:  1986 Mar-Apr       Impact factor: 6.447

9.  Apparent dose-dependent oral absorption of cyclosporin A in rats.

Authors:  C T Ueda; M Lemaire; G Gsell; P Misslin; K Nussbaumer
Journal:  Biopharm Drug Dispos       Date:  1984 Apr-Jun       Impact factor: 1.627

  9 in total
  25 in total

1.  Comparison of methods to calculate cyclosporine A bioavailability from consecutive oral and intravenous doses.

Authors:  M O Karlsson; A Lindberg-Freijs
Journal:  J Pharmacokinet Biopharm       Date:  1990-08

Review 2.  Oral bioavailability: issues and solutions via nanoformulations.

Authors:  Kamla Pathak; Smita Raghuvanshi
Journal:  Clin Pharmacokinet       Date:  2015-04       Impact factor: 6.447

3.  Solid self-microemulsifying formulation for candesartan cilexetil.

Authors:  Vijaykumar Nekkanti; Pradeep Karatgi; Raghavendra Prabhu; Raviraj Pillai
Journal:  AAPS PharmSciTech       Date:  2009-12-15       Impact factor: 3.246

4.  Oral absorption of FK506 in rats.

Authors:  A Kagayama; S Tanimoto; J Fujisaki; A Kaibara; K Ohara; K Iwasaki; Y Hirano; T Hata
Journal:  Pharm Res       Date:  1993-10       Impact factor: 4.200

5.  The effect of composition and gastric conditions on the self-emulsification process of ibuprofen-loaded self-emulsifying drug delivery systems: a microscopic and dynamic gastric model study.

Authors:  Annalisa Mercuri; Antonio Passalacqua; Martin S J Wickham; Richard M Faulks; Duncan Q M Craig; Susan A Barker
Journal:  Pharm Res       Date:  2011-02-24       Impact factor: 4.200

6.  Improving solubility and oral bioavailability of a novel antimalarial prodrug: comparing spray-dried dispersions with self-emulsifying drug delivery systems.

Authors:  Suresh Potharaju; Shravan Kumar Mutyam; Mingtao Liu; Carol Green; Lisa Frueh; Aaron Nilsen; Sovitj Pou; Rolf Winter; Michael K Riscoe; Gita Shankar
Journal:  Pharm Dev Technol       Date:  2020-02-12       Impact factor: 3.133

7.  Absorption and disposition of colloidal drug delivery systems. I. High-performance liquid chromatographic (HPLC) analysis of a cyclosporin emulsion.

Authors:  S J Corvari; R G Hollenbeck; J Leslie; K I Plaisance; D Young
Journal:  Pharm Res       Date:  1991-01       Impact factor: 4.200

8.  Influence of the type of surfactant and the degree of dispersion on the lymphatic transport of halofantrine in conscious rats.

Authors:  Ditte M Karpf; René Holm; Henning G Kristensen; Anette Müllertz
Journal:  Pharm Res       Date:  2004-08       Impact factor: 4.200

9.  Improved oral bioavailability of BCS class 2 compounds by self nano-emulsifying drug delivery systems (SNEDDS): the underlying mechanisms for amiodarone and talinolol.

Authors:  Anna Elgart; Irina Cherniakov; Yanir Aldouby; Abraham J Domb; Amnon Hoffman
Journal:  Pharm Res       Date:  2013-05-18       Impact factor: 4.200

10.  Development and validation of a HPLC method for dissolution and stability assay of liquid-filled cyclosporine capsule drug products.

Authors:  Xiaoming Xu; Abhay Gupta; Patrick Faustino; Pradeep M Sathe; Vilayat A Sayeed; Mansoor A Khan
Journal:  AAPS PharmSciTech       Date:  2013-06-13       Impact factor: 3.246

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.